{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:23:54Z","timestamp":1792686234105,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009325","name":"Canadian Health Services Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.hrthm.2025.07.002","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:26:34Z","timestamp":1752607594000},"page":"e1260-e1268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: Insights from the ARTESiA trial"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-4815","authenticated-orcid":false,"given":"Giuseppe","family":"Boriani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinthanie","family":"Ramasundarahettige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taya V.","family":"Glotzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Diemberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Cosedis","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidal","family":"Essebag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopinder K.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Benezet-Mazuecos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Mabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Coutu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Healey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2025.07.002_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.07.002_bib2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.07.002_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejim.2021.05.038","article-title":"Device-detected atrial high rate episodes and the risk of stroke\/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis","volume":"92","author":"Vitolo","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.hrthm.2025.07.002_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad226","article-title":"Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal","volume":"25","author":"Lip","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.002_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/europace\/euac144","article-title":"Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper","volume":"25","author":"Kalarus","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.002_bib6","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.07.002_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.07.002_bib8","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.07.002_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejim.2024.01.002","article-title":"Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: what decision making on anticoagulation after the NOAH and ARTESiA trials?","volume":"123","author":"Boriani","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.hrthm.2025.07.002_bib10","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1093\/eurheartj\/ehae365","article-title":"Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation","volume":"45","author":"Sanders","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.07.002_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.hrthm.2017.11.007","article-title":"Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden","volume":"15","author":"Boriani","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2025.07.002_bib12","first-page":"443","article-title":"Atrial high-rate episodes detected by cardiac implantable electronic devices: dynamic changes in episodes and predictors of incident atrial fibrillation","volume":"11","author":"Imberti","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.hrthm.2025.07.002_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ahj.2017.04.008","article-title":"Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial","volume":"189","author":"Lopes","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2025.07.002_bib15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.hroo.2021.11.006","article-title":"Atrial fibrillation and heart failure: a contemporary review of current management approaches","volume":"2","author":"Lee","year":"2021","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.hrthm.2025.07.002_bib14","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.jacc.2018.03.519","article-title":"Progression of device-detected subclinical atrial fibrillation and the risk of heart failure","volume":"71","author":"Wong","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.002_bib16","doi-asserted-by":"crossref","first-page":"euae112","DOI":"10.1093\/europace\/euae112","article-title":"Definition and management of arrhythmia-induced cardiomyopathy: findings from the European Heart Rhythm Association Survey","volume":"26","author":"Serban","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.002_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.002_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae298","article-title":"Spotlight on the 2024 ESC\/EACTS management of atrial fibrillation guidelines: 10 novel key aspects","volume":"26","author":"Rienstra","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.002_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad261","article-title":"Performance of a multi-sensor implantable defibrillator algorithm for heart failure monitoring in the presence of atrial fibrillation","volume":"25","author":"Boriani","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.002_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/eurheartj\/ehu307","article-title":"Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES","volume":"36","author":"Vanassche","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.07.002_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf019","article-title":"Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association","volume":"27","author":"Doehner","year":"2025","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.002_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022487","article-title":"Atrial high-rate episode duration thresholds and thromboembolic risk: a systematic review and meta-analysis","volume":"10","author":"Sagris","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2025.07.002_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad166","article-title":"The influence of atrial high-rate episodes on stroke and cardiovascular death: an update","volume":"25","author":"Toennis","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.002_bib24","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.124.069903","article-title":"Risk of stroke or systemic embolism according to baseline frequency and duration of subclinical atrial fibrillation: insights from the ARTESiA trial","volume":"150","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.07.002_bib25","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.123.067512","article-title":"Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"149","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.07.002_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae237","article-title":"Components of the Atrial Fibrillation Better Care pathway for holistic care of patients with atrial fibrillation: a win ratio analysis from the COOL-AF registry","volume":"26","author":"Krittayaphong","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.002_bib27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jacc.2024.05.002","article-title":"Apixaban vs aspirin according to CHA2DS2-VASc score in subclinical atrial fibrillation: insights from ARTESiA","volume":"84","author":"Lopes","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.002_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(24)00475-7","article-title":"Apixaban for stroke prevention in patients with subclinical atrial fibrillation and prior stroke or transient ischemic attack: a subgroup analysis of a double dummy, double blind, multicentre randomised, controlled trial","volume":"24","author":"Shoamanesh","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hrthm.2025.07.002_bib29","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1093\/eurheartj\/ehae596","article-title":"Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"45","author":"Schnabel","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.07.002_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae280","article-title":"Refining the CHA2DS2VASc risk stratification scheme: shall we drop the sex category criterion?","volume":"26","author":"Yoshimura","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.002_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae204","volume":"26","author":"Goette","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.002_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad233","article-title":"Remote monitoring of cardiac implantable electronic devices and disease management","volume":"25","author":"Varma","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.002_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad123","article-title":"2023 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on practical management of the remote device clinic","volume":"25","author":"Ferrick","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.002_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad202","article-title":"Cardiac pacing and lead devices management: 25 years of research at","volume":"25","author":"Defaye","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.002_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad176","article-title":"The digital journey: 25 years of digital development in electrophysiology from an Europace perspective","volume":"25","author":"Svennberg","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.002_bib36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/eurheartj\/ehad771","article-title":"Anticoagulation with edoxaban in patients with long atrial high-rate episodes \u226524 h","volume":"45","author":"Becher","year":"2024","journal-title":"Eur Heart J"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125026311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125026311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T07:20:21Z","timestamp":1778397621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527125026311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1547527125026311"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.07.002","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: Insights from the ARTESiA trial","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Heart Rhythm Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}